RF9 Powerfully Stimulates Gonadotrophin Secretion in the Ewe: Evidence for a Seasonal Threshold of Sensitivity
- 19 April 2012
- journal article
- research article
- Published by Wiley in Journal of Neuroendocrinology
- Vol. 24 (5) , 725-736
Abstract
GPR147 and its endogenous ligands, RFRPs, are emerging as important actors in hypothalamic‐pituitary axis control. The role of this system would be to inhibit gonadotrophin secretion. However, data on the subject are contradictory. The discovery of RF9 (adamantanecarbonyl‐RF‐2‐NH2), a GPR147 antagonist, prompted us to use this new tool to further investigate this system in the ewe. Accordingly, we tested the effect of i.c.v. administration of RF9 on gonadotrophin secretion in the ewe during anoestrous and the breeding season. Intracerebroventricular injections of RF9 (from 50–450 nmol) caused a clear elevation in peripheral blood plasma luteinising hormone (LH) concentrations. The effect of RF9 on LH was more pronounced during the anoestrous season. Furthermore, peripheral administration of RF9 as a bolus (2.1, 6.2 and 12.4 μmol per ewe) or as a constant i.v. infusion (2.1, 6.2, 12.4 and 18.6 μmol/h per ewe) to anoestrous acyclic ewes induced a sustained increase in LH plasma concentrations. A pharmacokinetic study showed that RF9 (12.4 μmol bolus i.v.) has an effective half life of 5.5 h in the plasma. Conversely, RF9 is not detectable in the cerebrospinal fluid, suggesting that it does not cross the blood–brain barrier. The increase in LH plasma concentrations induced by RF9 was blocked by previous administration of 1.3 μmol per ewe of gondotrophin‐releasing hormone (GnRH) antagonist Teverelix. This suggests that GnRH is involved in the stimulatory effect of RF9 on gonadotrophin secretion. Finally, no variation in LH plasma concentrations could be detected in ovariectomised ewes injected either i.c.v. or i.v. with RFRP3 (VPNLPQRF‐NH2). The lack of effect of RFRP3 in our experimental setting suggests that the mechanisms involved in RF9 action are probably more complex than previously assumed. Our results indicate that delivery of RF9 in the ewe greatly increases gondadotrophin secretion in both the oestrus and anoestrus season, suggesting a potential new way of controlling reproduction in mammals.Keywords
This publication has 48 references indexed in Scilit:
- Identification, Expression, and Physiological Functions of Siberian Hamster Gonadotropin-Inhibitory HormoneEndocrinology, 2012
- Human kisspeptins activate neuropeptide FF2 receptorNeuroscience, 2010
- Characterization of the inhibitory roles of RFRP3, the mammalian ortholog of GnIH, in the control of gonadotropin secretion in the rat: in vivo and in vitro studiesAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Discovery and Evolutionary History of Gonadotrophin‐Inhibitory Hormone and Kisspeptin: New Key Neuropeptides Controlling ReproductionJournal of Neuroendocrinology, 2010
- Insights into the mechanism by which kisspeptin stimulates a preovulatory LH surge and ovulation in seasonally acyclic ewes: Potential role of estradiolDomestic Animal Endocrinology, 2010
- Bovine C-terminal octapeptide of RFamide-related peptide-3 suppresses luteinizing hormone (LH) secretion from the pituitary as well as pulsatile LH secretion in bovinesDomestic Animal Endocrinology, 2009
- Evolutionary origin and divergence of GnIH and its homologous peptidesGeneral and Comparative Endocrinology, 2009
- Driving reproduction: RFamide peptides behind the wheelHormones and Behavior, 2006
- Peripheral administration of metastin induces marked gonadotropin release and ovulation in the ratBiochemical and Biophysical Research Communications, 2004
- A Novel Avian Hypothalamic Peptide Inhibiting Gonadotropin ReleaseBiochemical and Biophysical Research Communications, 2000